Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 63

Cited In for PubMed (Select 17142323)

1.

Ethanol exposure induces neonatal neurodegeneration by enhancing CB1R Exon1 histone H4K8 acetylation and up-regulating CB1R function causing neurobehavioral abnormalities in adult mice.

Subbanna S, Nagre NN, Umapathy NS, Pace BS, Basavarajappa BS.

Int J Neuropsychopharmacol. 2014 Oct 31;18(5). pii: pyu028. doi: 10.1093/ijnp/pyu028.

2.

CB1-receptor knockout neonatal mice are protected against ethanol-induced impairments of DNMT1, DNMT3A, and DNA methylation.

Nagre NN, Subbanna S, Shivakumar M, Psychoyos D, Basavarajappa BS.

J Neurochem. 2015 Feb;132(4):429-42. doi: 10.1111/jnc.13006. Epub 2015 Jan 27.

PMID:
25487288
3.

Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains.

Bai G, Cheung I, Shulha HP, Coelho JE, Li P, Dong X, Jakovcevski M, Wang Y, Grigorenko A, Jiang Y, Hoss A, Patel K, Zheng M, Rogaev E, Myers RH, Weng Z, Akbarian S, Chen JF.

Hum Mol Genet. 2015 Mar 1;24(5):1441-56. doi: 10.1093/hmg/ddu561. Epub 2014 Dec 5.

PMID:
25480889
4.

Anticancer drug mithramycin interacts with core histones: An additional mode of action of the DNA groove binder.

Banerjee A, Sanyal S, Kulkarni KK, Jana K, Roy S, Das C, Dasgupta D.

FEBS Open Bio. 2014 Oct 16;4:987-95. doi: 10.1016/j.fob.2014.10.007. eCollection 2014.

5.

The expanding role for chromatin and transcription in polyglutamine disease.

Mohan RD, Abmayr SM, Workman JL.

Curr Opin Genet Dev. 2014 Jun;26:96-104. doi: 10.1016/j.gde.2014.06.008. Epub 2014 Aug 11.

6.

Targeting the histone orthography of cancer: drugs for writers, erasers and readers.

Simó-Riudalbas L, Esteller M.

Br J Pharmacol. 2015 Jun;172(11):2716-32. doi: 10.1111/bph.12844. Epub 2014 Sep 5.

PMID:
25039449
7.

Pre-administration of G9a/GLP inhibitor during synaptogenesis prevents postnatal ethanol-induced LTP deficits and neurobehavioral abnormalities in adult mice.

Subbanna S, Basavarajappa BS.

Exp Neurol. 2014 Nov;261:34-43. doi: 10.1016/j.expneurol.2014.07.003. Epub 2014 Jul 11.

PMID:
25017367
8.

Epigenetic-based therapies for Friedreich ataxia.

Sandi C, Sandi M, Anjomani Virmouni S, Al-Mahdawi S, Pook MA.

Front Genet. 2014 Jun 3;5:165. doi: 10.3389/fgene.2014.00165. eCollection 2014. Review.

9.

Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective.

Valor LM.

Mol Neurobiol. 2015 Feb;51(1):406-23. doi: 10.1007/s12035-014-8715-8. Epub 2014 May 1.

10.

SETD6 controls the expression of estrogen-responsive genes and proliferation of breast carcinoma cells.

O'Neill DJ, Williamson SC, Alkharaif D, Monteiro IC, Goudreault M, Gaughan L, Robson CN, Gingras AC, Binda O.

Epigenetics. 2014 Jul;9(7):942-50. doi: 10.4161/epi.28864. Epub 2014 Apr 21.

11.

Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis.

Kumar A, Vaish M, Ratan RR.

Drug Discov Today. 2014 Jul;19(7):956-62. doi: 10.1016/j.drudis.2014.03.016. Epub 2014 Mar 21. Review.

12.

Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion.

Sun Y, Wei M, Ren SC, Chen R, Xu WD, Wang FB, Lu J, Shen J, Yu YW, Hou JG, Xu CL, Huang JT, Sun YH.

Asian J Androl. 2014 Mar-Apr;16(2):319-24. doi: 10.4103/1008-682X.122812.

13.

Transcriptional co-repressors and memory storage.

Schoch H, Abel T.

Neuropharmacology. 2014 May;80:53-60. doi: 10.1016/j.neuropharm.2014.01.003. Epub 2014 Jan 17. Review.

14.

Epigenetic mechanisms of Rubinstein-Taybi syndrome.

Park E, Kim Y, Ryu H, Kowall NW, Lee J, Ryu H.

Neuromolecular Med. 2014 Mar;16(1):16-24. doi: 10.1007/s12017-013-8285-3. Epub 2014 Jan 1.

15.

Ethanol induced acetylation of histone at G9a exon1 and G9a-mediated histone H3 dimethylation leads to neurodegeneration in neonatal mice.

Subbanna S, Nagre NN, Shivakumar M, Umapathy NS, Psychoyos D, Basavarajappa BS.

Neuroscience. 2014 Jan 31;258:422-32. doi: 10.1016/j.neuroscience.2013.11.043. Epub 2013 Dec 1.

16.

Neuroprotective effects of psychotropic drugs in Huntington's disease.

Lauterbach EC.

Int J Mol Sci. 2013 Nov 15;14(11):22558-603. doi: 10.3390/ijms141122558. Review.

17.

ESET methylates UBF at K232/254 and regulates nucleolar heterochromatin plasticity and rDNA transcription.

Hwang YJ, Han D, Kim KY, Min SJ, Kowall NW, Yang L, Lee J, Kim Y, Ryu H.

Nucleic Acids Res. 2014 Feb;42(3):1628-43. doi: 10.1093/nar/gkt1041. Epub 2013 Nov 14.

18.

Nucleolar dysfunction in Huntington's disease.

Lee J, Hwang YJ, Ryu H, Kowall NW, Ryu H.

Biochim Biophys Acta. 2014 Jun;1842(6):785-90. doi: 10.1016/j.bbadis.2013.09.017. Epub 2013 Oct 31. Review.

19.

Multiple Aspects of Gene Dysregulation in Huntington's Disease.

Moumné L, Betuing S, Caboche J.

Front Neurol. 2013 Oct 23;4:127. doi: 10.3389/fneur.2013.00127. Review.

20.

Epigenetics components of aging in the central nervous system.

Zhao YQ, Jordan IK, Lunyak VV.

Neurotherapeutics. 2013 Oct;10(4):647-63. doi: 10.1007/s13311-013-0229-y. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk